Check out our most popular compounded medications! Get Started
Our Terbinafine 50 mg/ml Oral Liquid is a specially crafted medication designed for oral use, ensuring a precise and consistent dose of terbinafine in each administration. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills, such as children and the elderly. Terbinafine is an antifungal agent commonly used to treat various fungal infections, including onychomycosis (fungal infection of the nails), tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm). The liquid form allows for flexible dosing and is ideal for those requiring tailored dosage strengths not available in standard tablet forms.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Terbinafine 50 mg/ml Oral Liquid is a custom-prepared medication designed to treat fungal infections by inhibiting the growth of fungi. It is also beneficial for those with impaired gastrointestinal function where absorption of the drug might be a concern with solid dosage forms.
The active ingredient, terbinafine, works by interfering with the fungal cell membrane's sterol biosynthesis, leading to the death of the fungal cell. This action is primarily fungicidal, meaning it actively kills the fungi, rather than just inhibiting its growth. Terbinafine is well-absorbed and can be taken with or without food, providing flexibility for patients. The oral liquid form allows for precise dosing, which is critical for achieving the desired therapeutic effect while minimizing potential side effects.
Terbinafine 50 mg/ml Oral Liquid is commonly prescribed for the treatment of onychomycosis (fungal nail infections), tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm of the body). It is also used in scalp infections and other conditions as determined by a healthcare provider. The duration of treatment varies depending on the location and severity of the infection, with nail infections typically requiring a longer course of therapy.
Patients and prescribers should be aware that while terbinafine is a well-tolerated medication, it can have side effects, and its use should be monitored by a healthcare professional. Liver function tests may be recommended before and during treatment, as terbinafine has been associated with liver enzyme abnormalities and, in rare cases, more serious liver damage. Other potential side effects include gastrointestinal disturbances, skin reactions, and taste disturbances.
For those interested in Terbinafine 50 mg/ml Oral Liquid, Bayview Pharmacy's team of compounding pharmacists is available to answer any questions and provide additional information. We ensure that each formulation is prepared with the utmost precision and care, tailored to meet the specific needs of each patient. If you have any questions or require further assistance, please do not hesitate to reach out to us.
Terbinafine is an antifungal medication that works by inhibiting the enzyme squalene epoxidase, which is a key component in the fungal cell membrane synthesis pathway. This action leads to a deficiency in ergosterol, an essential component of fungal cell membranes, and results in fungal cell death. Terbinafine is commonly used to treat various fungal infections, including onychomycosis (fungal infection of the nails), tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm).
When considering the use of terbinafine 50 mg/ml oral liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects. Terbinafine is metabolized primarily through the liver by the cytochrome P450 enzyme CYP2D6, and drugs that affect this enzyme can lead to altered levels of terbinafine. For example, CYP2D6 inhibitors such as fluoxetine, paroxetine, and quinidine may increase terbinafine levels, potentially leading to toxicity. Conversely, inducers of CYP2D6, such as rifampin and carbamazepine, may decrease terbinafine levels and reduce its effectiveness.
Terbinafine can also affect the metabolism of other drugs. It may decrease the clearance of drugs metabolized by CYP2D6, such as tricyclic antidepressants, beta-blockers, selective serotonin reuptake inhibitors (SSRIs), and monoamine oxidase inhibitors (MAOIs), potentially leading to increased plasma concentrations and risk of adverse effects. Additionally, terbinafine may increase the levels of caffeine and theophylline, necessitating monitoring and possible dose adjustments of these agents.
Patients taking terbinafine should also be cautioned about the potential for increased risk of bleeding when combined with anticoagulants such as warfarin, as terbinafine can potentiate the effects of warfarin. Close monitoring of prothrombin time or international normalized ratio (INR) is recommended in patients receiving both medications.
It is also important to note that terbinafine may interact with oral contraceptives, leading to irregular menstrual cycles or breakthrough bleeding. Patients should be advised to report any changes in their menstrual cycle to their healthcare provider.
Alcohol consumption should be minimized or avoided during terbinafine therapy, as concurrent use may increase the risk of hepatotoxicity. Patients should be advised to report any symptoms of liver dysfunction, such as jaundice, dark urine, or persistent nausea and vomiting.
Given the potential for significant drug interactions, it is crucial for patients and prescribers to review all current medications, including over-the-counter drugs and herbal supplements, before initiating treatment with terbinafine oral liquid. Adjustments to therapy or additional monitoring may be necessary to ensure safe and appropriate use of this medication.
If you have any questions or require further information regarding drug interactions with terbinafine 50 mg/ml oral liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support to ensure the safe and appropriate use of our formulations.
Terbinafine is an antifungal medication that works by inhibiting the enzyme squalene epoxidase, which is found on the fungal cell membrane. This enzyme is essential for the synthesis of ergosterol, a key component of fungal cell membranes. By disrupting the production of ergosterol, terbinafine compromises the structural integrity of the fungal cell membrane, leading to cell death and ultimately the resolution of the fungal infection. The 50 mg/ml oral liquid formulation of terbinafine provides a precise concentration that allows for accurate dosing, which is particularly important in achieving the desired therapeutic effect while minimizing potential side effects.
The terbinafine oral liquid is particularly beneficial for patients who have difficulty swallowing pills, such as children and the elderly, or for those who may have conditions that affect their ability to swallow solid dosage forms. The liquid formulation allows for flexible dosing, which can be adjusted according to the patient's weight, the severity of the infection, and the specific type of fungal infection being treated. This formulation is used to treat a variety of fungal infections, including onychomycosis (fungal infection of the nails), tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm of the body). It is important to note that the duration of treatment with terbinafine oral liquid can vary depending on the location and severity of the infection, and it may take several weeks to see complete resolution of symptoms.
For patients and prescribers considering the use of terbinafine 50 mg/ml oral liquid, it is essential to adhere to the prescribed dosing regimen and to complete the full course of therapy, even if symptoms improve before the medication is finished, to ensure the infection is fully eradicated and to prevent resistance. As with any medication, there may be potential side effects, and it is important to monitor for any adverse reactions. If you have any questions about the terbinafine oral liquid formulation or its use in treating fungal infections, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
Terbinafine 50 mg/ml Oral Liquid is used to treat fungal infections of the nails and skin, such as onychomycosis, ringworm or athlete's foot, by inhibiting the growth of the fungus. It may be prescribed for other conditions as determined by your healthcare provider.
This medication should be taken exactly as prescribed by your healthcare provider. Typically, it is taken once daily, but the exact dosage and duration of treatment will depend on the condition being treated and the patient's response to therapy. The liquid form makes it easy to swallow, especially for those who have difficulty with pills.
Yes, Terbinafine Oral Liquid can be prescribed for children when deemed appropriate by a healthcare provider. The liquid formulation is particularly useful for children who may have difficulty swallowing tablets or capsules.
Yes, the oral liquid is often suitable for elderly patients, especially those who may have trouble swallowing solid dosage forms. However, dosages may need to be adjusted based on kidney function, liver function, and overall health. Always consult with a healthcare provider before use.
If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take two doses at one time to make up for a missed dose.
Store the medication at room temperature, away from light and moisture. Keep the bottle tightly closed when not in use. Always check the expiration date and do not use if the liquid has expired. Consult the medication guide or your pharmacist for specific storage instructions.
Yes, Terbinafine can interact with various other medications, which can affect how it works or increase the risk of serious side effects. It is essential to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements.
Similar to other medications, Terbinafine Oral Liquid can cause side effects, though not everyone experiences them. Common side effects include gastrointestinal issues such as diarrhea, upset stomach, and taste disturbances. If you experience severe side effects or signs of an allergic reaction, contact your healthcare provider immediately.
It is generally recommended to avoid alcohol while taking Terbinafine, as consuming alcohol might increase the risk of certain side effects or liver damage. Consult with your healthcare provider for advice tailored to your personal health circumstances.
The duration of treatment with Terbinafine Oral Liquid varies depending on the type and severity of the infection. Some patients may need to take the medication for several weeks, while others may require treatment for a few months. Follow your healthcare provider’s instructions carefully regarding the length of your treatment.
Terbinafine can affect the liver, and in rare cases, it may cause serious liver problems. Your healthcare provider may order liver function tests before and during treatment to monitor for any potential issues. If you notice symptoms such as persistent nausea, loss of appetite, fatigue, vomiting, right upper abdominal pain, dark urine, or jaundice, contact your healthcare provider immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
